Close

Dr Rebecca Glover

MA MSc PhD

Assistant Professor
Health Services Research

Room
133

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Rebecca Glover is the head of Economic, Social, and Political Sciences in the Antimicrobial Resistance Centre at LSHTM. Since 2016, she has worked as a research fellow and then an assistant professor in the Policy Innovation and Evaluation Research Unit (PIRU) on several evaluations, notably two evaluations of the UK AMR 2013-18 Strategy, and the 2019-2024 National Action Plan.  She also completed a PhD in the department of Public Health, Environments, and Society (PHES) examining the role of rapid diagnostic tests for bacterial identification and antibiotic susceptibility testing in secondary care in the UK. 

 

She previously completed her MSc in the Control of Infectious Diseases at LSHTM in 2014, and then joined LSHTM's Ebola team, where she split her time evenly between the Public Trust team and the Centre for the Mathematical Modelling of Infectious Diseases (cmmid.lshtm.ac.uk).

Affiliations

Department of Health Services Research and Policy
Faculty of Public Health and Policy

Centres

Antimicrobial Resistance Centre (AMR)

Teaching

Rebecca currently is the module co-organiser of Applied Communicable Disease Control, and previously taught on Epidemiology and the Control of Communicable Diseases.

Research

Rebecca is currently researching infectious disease policy, equitable policy responses to pandemics, and the commercial determinants of health.  She is accepting PhD student applications at the intersection of these areas.  She has a particular interest in interdisciplinarity and mixed methods research. 

Research Area
Bacteria
Complex interventions
Diagnostics
Drug resistance
Health policy
Health services research
Infectious disease policy
Social and structural determinants of health
Systematic reviews
Disease control
Equity
Evaluation
Evidence use
Implementation research
Discipline
Epidemiology
Policy analysis
Social Sciences
Disease and Health Conditions
Infectious disease
Emerging Infectious Disease
Country
United Kingdom
Region
European Union
OECD members

Selected Publications

Methodological guidance for incorporating equity when informing rapid-policy and guideline development.
Dewidar O; Kawala BA; Antequera A; Tricco AC; Tovey D; Straus S; Glover R; Tufte J; Magwood O; Smith M
2022
Journal of clinical epidemiology
Sale of UK's Vaccine Manufacturing and Innovation Centre.
Glover RE; Roberts AP; Singer AC; Kirchhelle C
2022
BMJ (Clinical research ed.)
The antibiotic subscription model: fostering innovation or repackaging old drugs?
Glover RE; Singer AC; Roberts AP; Kirchhelle C
2022
The Lancet. Microbe
Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END).
McCaul M; Tovey D; Young T; Welch V; Dewidar O; Goetghebeur M; Kredo T; Tricco AC; Glover RE; Tufte J
2022
Journal of clinical epidemiology
See more Publications